Hi all
I think an obvious source of funds for the continuing development of the Cardiocell business would be to sell off that part of of our business which is the agency sales of infusion products to local hospitals. Profitable but a small "mum and pop" sized operation. Maybe worth $8 mill or so. Has no value in regards to long term strategy, so why not? Might just allow us to scrape through another year to where the Cardiocell sales turn profitable.
Cheers
Capital raising share dilution, page-18
Add AVR (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$15.15 |
Change
0.000(0.00%) |
Mkt cap ! $291.2M | |||
| Open | High | Low | Value | Volume |
| $15.00 | $15.15 | $14.60 | $347.8K | 23.20K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 760 | $15.00 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $15.15 | 388 | 1 |
View Market Depth
| Last trade - 15.58pm 30/07/2024 (20 minute delay) ? |
| AVR (ASX) Chart |